You need to log in or sign up before continuing.  

Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Powered By

Top 10 search results for "trials" in Resources. To see all results and access other features, sign up for free.

... References HIV Treatment: The Basics — HIVinfo.NIH.gov The Stages of HIV Infection — HIVinfo.NIH.gov Antiretroviral Therapy (ART) — ClinicalInfo.HIV.gov Retrovirus — National Human Genome Research Institute HIV and AIDS Clinical Trials — HIVinfo.NIH.gov What To Start: Choosing an HIV Treatment Regimen — HIVinfo.NIH.gov HIV Medicines and Side Effects ...
Treatment for HIV
... References HIV Treatment: The Basics — HIVinfo.NIH.gov The Stages of HIV Infection — HIVinfo.NIH.gov Antiretroviral Therapy (ART) — ClinicalInfo.HIV.gov Retrovirus — National Human Genome Research Institute HIV and AIDS Clinical Trials — HIVinfo.NIH.gov What To Start: Choosing an HIV Treatment Regimen — HIVinfo.NIH.gov HIV Medicines and Side Effects ...
... Although both the oral and injectable drugs were considered “highly effective,” the study authors concluded Apretude was even more effective because it was easier to take consistently.In clinical trials to date, researchers have found injectable cabotegravir taken either every month or every two months to be well tolerated. ...
Injectables for HIV Treatment and Prevention: How They Work
... Although both the oral and injectable drugs were considered “highly effective,” the study authors concluded Apretude was even more effective because it was easier to take consistently.In clinical trials to date, researchers have found injectable cabotegravir taken either every month or every two months to be well tolerated. ...
... The most common side effects experienced by patients treated with Spravato in the clinical trials were dissociation, dizziness, nausea, sedation, vertigo, decreased feeling or sensitivity (hypoesthesia), anxiety, lethargy, increased blood pressure, vomiting and feeling drunk," the agency said.Because of these potential effects, people with high blood ...
FDA Approves Ketamine-Like Drug for Severe Depression
... The most common side effects experienced by patients treated with Spravato in the clinical trials were dissociation, dizziness, nausea, sedation, vertigo, decreased feeling or sensitivity (hypoesthesia), anxiety, lethargy, increased blood pressure, vomiting and feeling drunk," the agency said.Because of these potential effects, people with high blood ...
... It’s also approved for treating nausea in people with cancer who are receiving chemotherapy.Clinical trials in people with HIV have found that dronabinol stimulates the appetite. One study from the Journal of Acquired Immune Deficiency Syndromes evaluated the effects of dronabinol in 10 people living with HIV who normally smoked marijuana. ...
Medical Marijuana and HIV: Can It Help?
... It’s also approved for treating nausea in people with cancer who are receiving chemotherapy.Clinical trials in people with HIV have found that dronabinol stimulates the appetite. One study from the Journal of Acquired Immune Deficiency Syndromes evaluated the effects of dronabinol in 10 people living with HIV who normally smoked marijuana. ...
... Studies investigating the effects of vitamin D supplementation have had mixed results, and there’s not much information from research trials about the best amount of vitamin D for adults with HIV. ...
Vitamin D and HIV: What’s the Connection?
... Studies investigating the effects of vitamin D supplementation have had mixed results, and there’s not much information from research trials about the best amount of vitamin D for adults with HIV. ...
... Two ongoing clinical trials are exploring the effects of semaglutide in this population. A study in Ireland is looking into whether semaglutide can help people with HIV lose weight. In the United States, a study is examining whether semaglutide can reduce fat buildup in people with HIV. ...
GLP-1 Drugs and HIV: Is It Safe To Take Them With Your Meds?
... Two ongoing clinical trials are exploring the effects of semaglutide in this population. A study in Ireland is looking into whether semaglutide can help people with HIV lose weight. In the United States, a study is examining whether semaglutide can reduce fat buildup in people with HIV. ...
... No clinical trials show whether CBD helps with nausea in the same way as dronabinol. ...
CBD for HIV: Is It Effective?
... No clinical trials show whether CBD helps with nausea in the same way as dronabinol. ...
... ReferencesWeight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials — Clinical Infectious DiseasesPeople With HIV Gain Weight Faster Than HIV-Negative People — NAM aidsmapHIV-Related Immune Activation May Predict Weight Gain and Exacerbate Complications, Especially in Women — HIV.govChanges to ...
How To Talk to Your Doctor About Weight Gain and HIV
... ReferencesWeight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials — Clinical Infectious DiseasesPeople With HIV Gain Weight Faster Than HIV-Negative People — NAM aidsmapHIV-Related Immune Activation May Predict Weight Gain and Exacerbate Complications, Especially in Women — HIV.govChanges to ...
... Until controlled clinical trials can show the benefits and safety of IF for people with HIV, it’s not clear if you can expect the same results. That’s why you should always talk to your doctor before trying any fasting diet.Religious Fasting With HIVReligious fasting is meant to benefit the spirit, but it can bring physical benefits as well. ...
Fasting and HIV: Can It Help?
... Until controlled clinical trials can show the benefits and safety of IF for people with HIV, it’s not clear if you can expect the same results. That’s why you should always talk to your doctor before trying any fasting diet.Religious Fasting With HIVReligious fasting is meant to benefit the spirit, but it can bring physical benefits as well. ...
... In recent late-stage clinical trials, nearly 100 percent of participants remained HIV-negative on Yetztugo.It’s important to talk to your primary care provider or an emergency room doctor as soon as you think you’ve been exposed to HIV. ...
HIV: Cause, Prevention, and Risk Factors
... In recent late-stage clinical trials, nearly 100 percent of participants remained HIV-negative on Yetztugo.It’s important to talk to your primary care provider or an emergency room doctor as soon as you think you’ve been exposed to HIV. ...